BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37940035)

  • 1. Situation of onchocerciasis transmission in 2020 in the Cascades region of Burkina Faso.
    Guiguemde KT; Sawadogo PM; Zida A; Kima A; Bougma RW; Serme M; Sangaré I; Bougouma C; Bamba S
    Parasitol Int; 2024 Feb; 98():102822. PubMed ID: 37940035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onchocerciasis prevalence, human migration and risks for onchocerciasis elimination in the Upper Mouhoun, Nakambé and Nazinon river basins in Burkina Faso.
    Nikièma AS; Koala L; Post RJ; Paré AB; Kafando CM; Drabo F; Belem AMG; Dabiré RK; Traoré S
    Acta Trop; 2018 Sep; 185():176-182. PubMed ID: 29782820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
    Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.
    Nikièma AS; Koala L; Post RJ; Kima A; Compaoré J; Kafando CM; Nana JB; Bougouma C; Faye B; Traoré S; Dabiré RK
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012118. PubMed ID: 38683750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
    Koala L; Nikiema A; Post RJ; Paré AB; Kafando CM; Drabo F; Traoré S
    Acta Trop; 2017 Feb; 166():96-105. PubMed ID: 27845063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the current status of onchocerciasis in Côte d'Ivoire following 40 years of intervention: Progress and challenges.
    Koudou BG; Kouakou MM; Ouattara AF; Yeo S; Brika P; Meite A; Aba E; King CL; Kouakou R; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006897. PubMed ID: 30352058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards onchocerciasis elimination in Côte d'Ivoire: A geospatial modelling study.
    Eneanya OA; Koudou BG; Aboulaye M; Elvis AA; Souleymane Y; Kouakou MM; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009091. PubMed ID: 33566805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
    Soungalo T; Soumana D; Moussa S; François R
    Acta Trop; 1997 Dec; 68(3):297-300. PubMed ID: 9492914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entomological assessment of the transmission following recrudescence of onchocerciasis in the Comoé Valley, Burkina Faso.
    Koala L; Nikièma AS; Paré AB; Drabo F; Toé LD; Belem AMG; Boakye DA; Traoré S; Dabiré RK
    Parasit Vectors; 2019 Jan; 12(1):34. PubMed ID: 30646934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
    Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
    Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of migrants infected with Onchocerca volvulus in west African river valleys protected by 14 to 15 years of Simulium control.
    De Sole G; Remme J
    Trop Med Parasitol; 1991 Jun; 42(2):75-8. PubMed ID: 1654591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
    Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
    Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
    Efon-Ekangouo A; Nana-Djeunga HC; Nzune-Toche N; Dongmo-Yemele R; Bopda J; Ongbassomben V; Sumo L; Geiger A; Nutman TB; Kamgno J
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011250. PubMed ID: 37058547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Onchocerciasis in Burkina Faso: a Re-Emerging Vector-Borne Endemic Disease].
    Sawadogo PM; Bougouma C; Zida A; Compaoré J; Guiguemdé TK; Sangaré I; Kaboré D; Bamba S; Guiguemdé TR
    Bull Soc Pathol Exot; 2019; 112(5):260-274. PubMed ID: 32880127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity.
    Lipner EM; Dembele N; Souleymane S; Alley WS; Prevots DR; Toe L; Boatin B; Weil GJ; Nutman TB
    J Infect Dis; 2006 Jul; 194(2):216-21. PubMed ID: 16779728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration studies in the onchocerciasis controlled areas of West Africa.
    De Sole G
    Trop Med Parasitol; 1990 Mar; 41(1):33-6. PubMed ID: 2160121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs.
    Hamley JID; Milton P; Walker M; Basáñez MG
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007557. PubMed ID: 31805049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
    Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Tendongfor N; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Kah E; Enyong P; Taylor DW
    Parasit Vectors; 2015 Apr; 8():202. PubMed ID: 25886166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
    Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
    BMC Public Health; 2020 Aug; 20(1):1233. PubMed ID: 32787813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.